Syphilis: Difference between revisions

(Text replacement - " HIV " to " HIV ")
(7 intermediate revisions by 5 users not shown)
Line 25: Line 25:
*They progress to more wide spread papular lesions that frequently involve the palms and soles.
*They progress to more wide spread papular lesions that frequently involve the palms and soles.
**Appears 6-8 weeks after the chancre heals and subsides within 2-6 weeks
**Appears 6-8 weeks after the chancre heals and subsides within 2-6 weeks
**Healing chancre may still be present in ~15% of cases. The stages may overlap more frequently in HIV patients. <ref>Chesson HW, Heffelfinger JD, Voigt RF, Collins D. Estimates of primary and secondary syphilis rates in persons with HIV in the United States, 2002. Sex Transm Dis 2005; 32:265. </ref>
**Healing chancre may still be present in ~15% of cases. The stages may overlap more frequently in [[HIV]] patients. <ref>Chesson HW, Heffelfinger JD, Voigt RF, Collins D. Estimates of primary and secondary syphilis rates in persons with [[HIV]] in the United States, 2002. Sex Transm Dis 2005; 32:265. </ref>
**In intertriginous areas, papules can enlarge to produce broad, moist, pink or gray-white infectious lesions called condylomata lata  
**In intertriginous areas, papules can enlarge to produce broad, moist, pink or gray-white infectious lesions called condylomata lata  
*CSF abnormalities are detected in as many as 40% during this stage. CNS involvement can be symptomatic or asymptomatic.  
*CSF abnormalities are detected in as many as 40% during this stage. CNS involvement can be symptomatic or asymptomatic.  
Line 36: Line 36:
===Tertiary Syphilis===
===Tertiary Syphilis===
*Characterized by progressively destructive mucocutaneous, musculoskeletal, or parenchymal lesions, aortitis or CNS manifestations
*Characterized by progressively destructive mucocutaneous, musculoskeletal, or parenchymal lesions, aortitis or CNS manifestations
*The most common manifestation in the US today is neurosyphilis in HIV infected persons.
*The most common manifestation in the US today is neurosyphilis in [[HIV]] infected persons.
*Historical manifestations:  
*Historical manifestations:  
**Gumma: granulomatous lesion  
**Gumma: granulomatous lesion  
Line 43: Line 43:
===System Specific===
===System Specific===
'''CNS'''
'''CNS'''
*CSF-VDRL preferred test<ref>Marra CM, Tantalo LC, Maxwell CL, Ho EL, Sahi SK, Jones T. The rapid plasma reagin test cannot replace the venereal disease research laboratory test for neurosyphilis diagnosis. Sex Transm Dis. 2012 Jun;39(6):453-7.</ref>
*Continuum of involvement from asymptomatic patient with CSF abnormalities to meningitis and focal neurologic deficits  
*Continuum of involvement from asymptomatic patient with CSF abnormalities to meningitis and focal neurologic deficits  
*RPR titers of ≥ 1:32 are at higher risk of having neurosyphilis, even higher if HIV infected.
*RPR titers of ≥ 1:32 are at higher risk of having neurosyphilis, even higher if [[HIV]] infected.
*Demonstrable in up to 25% of patients with latent infection and up to 40% of primary or secondary cases <ref>Lukehart SA. Chapter 169. Syphilis. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson J, Loscalzo J. eds. Harrison's Principles of Internal Medicine, 18e.New York, NY: McGraw-Hill; 2012</ref>
*Demonstrable in up to 25% of patients with latent infection and up to 40% of primary or secondary cases <ref>Lukehart SA. Chapter 169. Syphilis. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson J, Loscalzo J. eds. Harrison's Principles of Internal Medicine, 18e.New York, NY: McGraw-Hill; 2012</ref>
**Patients with early syphilis who have CSF findings may need to be treated as with neurosyphilis, especially in the setting of HIV
**Patients with early syphilis who have CSF findings may need to be treated as with neurosyphilis, especially in the setting of HIV
Line 99: Line 100:
*[[Lyme Disease]]
*[[Lyme Disease]]


==Diagnosis==
{{STD DDX}}
 
==Evaluation==
'''Nontreponemal Tests:'''<ref name="test">Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin. Microbiol. Rev. 1995;8(1):1–21.</ref>
'''Nontreponemal Tests:'''<ref name="test">Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin. Microbiol. Rev. 1995;8(1):1–21.</ref>
*Rapid Plamsa Reagin (RPR)*
*Rapid Plamsa Reagin (RPR)*
Line 116: Line 119:


'''CSF'''
'''CSF'''
*Pleocytosis (>5 WBC/uL), increased protein (>45 mg/dL) or VDRL reactivity
*Pleocytosis (>5 WBC/uL), increased protein (>45mg/dL) or VDRL reactivity
*May be confounded by HIV infection<ref>Ghanem KG1, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. Clin. Infect Dis. 2009 Mar 15;48(6):816-21.</ref>  
*May be confounded by [[HIV]] infection<ref>Ghanem KG1, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. Clin. Infect Dis. 2009 Mar 15;48(6):816-21.</ref>  
*CSF VDRL test is highly specific but is relatively insensitive. Further testing with treponemal antibodies may be necessary.  
*CSF VDRL test is highly specific but is relatively insensitive. Further testing with treponemal antibodies may be necessary.  


'''HIV-infected patients'''
'''HIV-infected patients'''
*All newly diagnosed HIV patients should be tested for syphilis and vice versa
*All newly diagnosed [[HIV]] patients should be tested for syphilis and vice versa
*RPR titer and CD4 count can be used to identify patients at higher risk for neurosyphilis for lumbar puncture
*RPR titer and CD4 count can be used to identify patients at higher risk for neurosyphilis for lumbar puncture


==Management==
==Management==
Treatment is primary with penicillin with dosing and type of penicillin determined by the stage of disease<ref>Kaplan JE, Benson C, Holmes KH, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(RR-4):1–207</ref>  
Treatment is primary with penicillin with dosing and type of penicillin determined by the stage of disease<ref>Kaplan JE, Benson C, Holmes KH, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the [[HIV]] Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(RR-4):1–207</ref>  


'''Treat those exposed within the past 3 months.'''
'''Treat those exposed within the past 3 months.'''
Line 158: Line 161:


==Disposition==
==Disposition==
*Primary and late stage syphilis can be discharge however close follow up should be provided for each with primary care or health department
*Primary and late stage syphilis can be discharge however close follow up should be provided for each with primary care provider or health department
*Neurosyphilis should be admitted  
*Neurosyphilis should be admitted


==See Also==
==See Also==
Line 166: Line 169:
==References==
==References==
<references/>
<references/>
[[Category:Derm]]
[[Category:Dermatology]]
[[Category:GU]]
[[Category:Urology]]
[[Category:ID]]
[[Category:ID]]

Revision as of 15:48, 8 September 2016

Background

  • Syphilis is caused by the spirochete Treponema pallidum. [1]
  • Usually sexually transmitted
  • Causes a wide range of systemic manifestations that are characterized by episodes of active disease interrupted by periods of latency
  • Approximately 30% of asymptomatic contacts examined within 30 days of exposure have infection

Pathogenesis

  • Spirochetes penetrate intact mucous membranes or microscopic dermal abrasions.
  • Transmission through sexual contact with infectious lesions, infection in utero, blood transfusion, and organ transplantation[2]
  • Blood from a patient with incubating or early syphilis is infectious.
  • Characterized by multiple stages separated by periods of latency: primary, secondary, latent and tertiary

Clinical Features

Primary syphalis on penile shaft

Primary Syphilis

  • Primary lesion appears after an incubation of 2-6 weeks
    • Single painless papule that becomes eroded and indurated, cartilaginous consistency on palpation
    • Minority of patients can have multiple lesions or atypical appearance
    • Occurs at point of contact: penis, rectum, mouth, external genitalia, cervix, or labia
    • Heals in 4-6 weeks
  • Regional lymphadenopathy that is painless and firm

Secondary Syphilis

  • Characterized by generalized mucocutaneous lesions and lymphadenopathy but can also be found in other tissues[3]
  • Skin lesions are usually maculopapular, pale red or pink, non-pruritic, discrete, and distributed on the trunk and proximal extremities. They may be subtle.
  • They progress to more wide spread papular lesions that frequently involve the palms and soles.
    • Appears 6-8 weeks after the chancre heals and subsides within 2-6 weeks
    • Healing chancre may still be present in ~15% of cases. The stages may overlap more frequently in HIV patients. [4]
    • In intertriginous areas, papules can enlarge to produce broad, moist, pink or gray-white infectious lesions called condylomata lata
  • CSF abnormalities are detected in as many as 40% during this stage. CNS involvement can be symptomatic or asymptomatic.
  • Constitutional symptoms may accompany or precede secondary syphilis. Can include: sore throat, fever, weight loss, malaise, anorexia, headache, and meningismus
  • Less common complications include: hepatitis, nephropathy, gastritis, proctitis, rectosigmoid mass arthritis, periositis, optic neuritis, iritis, uveitis, pupillary abnormalities

Latent Syphilis

  • Detectable by serologic testing only
  • May intermittently be present in the bloodstream and transmitted through blood transfusion or organ donation
  • Spontaneous cure is rare

Tertiary Syphilis

  • Characterized by progressively destructive mucocutaneous, musculoskeletal, or parenchymal lesions, aortitis or CNS manifestations
  • The most common manifestation in the US today is neurosyphilis in HIV infected persons.
  • Historical manifestations:
    • Gumma: granulomatous lesion
    • Cardiovascular syphilis: involves the vasa vasorum of the ascending aorta and can result in aneurysm formation
    • Late symptomatic neurosyphilis: tabes dorsalis and paresis

System Specific

CNS

  • CSF-VDRL preferred test[5]
  • Continuum of involvement from asymptomatic patient with CSF abnormalities to meningitis and focal neurologic deficits
  • RPR titers of ≥ 1:32 are at higher risk of having neurosyphilis, even higher if HIV infected.
  • Demonstrable in up to 25% of patients with latent infection and up to 40% of primary or secondary cases [6]
    • Patients with early syphilis who have CSF findings may need to be treated as with neurosyphilis, especially in the setting of HIV
  • Meningeal: Headache, nausea, vomiting, neck stiffness, cranial nerve involvement, seizures, changes in mental status, uveitis, iritis or hearing loss
  • Meningovascular: Meningitis together with inflammatory vasculitis leading to stroke syndrome
    • Subacute encephalitic prodrome of headaches, vertigo, insomnia, and psychological abnormalities
  • Parenchymal: Paresis, hyperactive reflexes, Argyll Robertson pupils, illusions/delusions/hallucinations, memory defects, speech changes.
    • Argyll Robertson pupil: small, irregular pupil that reacts to accommodation but not to light
    • Tabes dorsalis presents with a wide based gait ataxia, foot drop, paresthesias, bladder dysfunction, impotence, areflexia, loss of positional, deep pain and temperature sensations• Cardiovascular

Cardiovascular

  • 10-40 years after infection
  • Endarteritis obliterans of the vasa vasorum leads
  • Aortitis, aortic regurgitation, saccular aneurysm (usually ascending), coronary ostial stenosis

Gumma

  • Commonly involves skin and skeletal system
  • Solitary lesions ranging from microscopic to several centimeters
  • Granulomatous inflammation with central area of necrosis due to endarteritis obliterans
  • Painless, indurate nodular or ulcerative lesions

Congenital Syphilis

  • Transmission across the placenta may occur at any stage of pregnancy[7]
  • Treatment before the 16th week of pregnancy should prevent fetal damage
  • Treatment before the third trimester should treat the infected fetus
  • Most common clinical problem is a healthy-appearing baby with a positive serologic test

Differential Diagnosis

Sexually transmitted diseases

Evaluation

Nontreponemal Tests:[8]

  • Rapid Plamsa Reagin (RPR)*
    • Faster and easier to perform
  • Venereal Disease Research Laboratory (VDRL)*
    • Standard for CSF examination
  • Toludine Red Unheated Serum Test (TRUST)

Most commonly in the ED, the VDRL and RPR will be the ordered screening test

Treponemal Test:[8]

  • Fluorescent treponemal antibody absorption (FTA-ABS)
  • Microhemagglutination test for antibodies to Treponema pallidum (MHA-TP)
  • Treponemal pallidum particle agglutination assay (TP-PA)
  • Treponema pallidum enzyme immunoassay (TP-EIA)

CSF

  • Pleocytosis (>5 WBC/uL), increased protein (>45mg/dL) or VDRL reactivity
  • May be confounded by HIV infection[9]
  • CSF VDRL test is highly specific but is relatively insensitive. Further testing with treponemal antibodies may be necessary.

HIV-infected patients

  • All newly diagnosed HIV patients should be tested for syphilis and vice versa
  • RPR titer and CD4 count can be used to identify patients at higher risk for neurosyphilis for lumbar puncture

Management

Treatment is primary with penicillin with dosing and type of penicillin determined by the stage of disease[10]

Treat those exposed within the past 3 months.

Early Stage

This is classified as primary, secondary, and early latent syphilis less than one year.

Treatment Options:

  • Penicillin G Benzathine 2.4 million units IM x 1
    • Repeat dose after 7 days for pregnant patients and HIV infection
  • Doxycycline 100mg oral twice daily for 14 days as alternative

Late Stage

Late stage is greater than one year duration, presence of gummas, or cardiovascular disease

Treatment Options:

Neurosyphilis

There are 3 Major options with none showing greater efficacy than others:

  • Penicillin G 3-4 million units IV every 4 hours x 10-14 days
  • Penicillin G 24 million units continuous IV infusion x 10-14 days
  • Penicillin G Procaine2.4 million units IM daily + probenecid 500mg oral every 6 hours for 10-14 days.
  • Alternative:
  • Desensitization to the penicillin allergy is still the preferred method of treatment for patients with early and late stage disease (especially during pregnancy)

Pregnancy

  • Penicillin, dosage depends on stage [11]

Jarisch-Herxheimer Reaction

  • Reaction to treatment consisting of fever, chills, myalgias, headache, tachycardia, increased respiratory rate, leukocytosis, vasodilation with mild hypotension
  • Usually resolves within 12-24 hours
  • Symptom based treatment

Disposition

  • Primary and late stage syphilis can be discharge however close follow up should be provided for each with primary care provider or health department
  • Neurosyphilis should be admitted

See Also

References

  1. Lukehart SA. Chapter 169. Syphilis. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson J, Loscalzo J. eds. Harrison's Principles of Internal Medicine, 18e.New York, NY: McGraw-Hill; 2012.
  2. Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010;59(RR-12):1–110.
  3. Chapel TA. The signs and symptoms of secondary syphilis. Sex Transm Dis. 1980;7(4):161–164.1.
  4. Chesson HW, Heffelfinger JD, Voigt RF, Collins D. Estimates of primary and secondary syphilis rates in persons with HIV in the United States, 2002. Sex Transm Dis 2005; 32:265.
  5. Marra CM, Tantalo LC, Maxwell CL, Ho EL, Sahi SK, Jones T. The rapid plasma reagin test cannot replace the venereal disease research laboratory test for neurosyphilis diagnosis. Sex Transm Dis. 2012 Jun;39(6):453-7.
  6. Lukehart SA. Chapter 169. Syphilis. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson J, Loscalzo J. eds. Harrison's Principles of Internal Medicine, 18e.New York, NY: McGraw-Hill; 2012
  7. Rosenberg AA, Grover T. The Newborn Infant. In: Hay WW, Jr., Levin MJ, Deterding RR, Abzug MJ. eds. CURRENT Diagnosis & Treatment: Pediatrics, 22e.New York, NY: McGraw-Hill; 2013.
  8. 8.0 8.1 Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin. Microbiol. Rev. 1995;8(1):1–21.
  9. Ghanem KG1, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. Clin. Infect Dis. 2009 Mar 15;48(6):816-21.
  10. Kaplan JE, Benson C, Holmes KH, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(RR-4):1–207
  11. Mackay G. Chapter 43. Sexually Transmitted Diseases & Pelvic Infections. In:DeCherney AH, Nathan L, Laufer N, Roman AS. eds. CURRENT Diagnosis & Treatment: Obstetrics & Gynecology, 11e. New York, NY: McGraw-Hill; 2013